Home › NDC Lookup › RxCUI directory › RxCUI 1597570

Buprenorphine 11.4 MG / naloxone 2.9 MG Sublingual Tablet [Zubsolv] — RxCUI 1597570

RxNorm drug concept · Semantic branded drug
RxCUI 1597570 Semantic branded drug · SBD ● Current RxNorm concept 12 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1597570
Official nameBuprenorphine 11.4 MG / naloxone 2.9 MG Sublingual Tablet [Zubsolv]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known aszubsolv 11.4 MG / 2.9 MG Sublingual Tablet
FDA products mapped12
Package NDCs mapped12
Reported Medicaid activity (SDUD)115,191 prescriptions · 44 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Naloxone Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Naloxone works by knocking opioids off their receptors in the brain — the spots opioids attach to in order to cause their effects. When those receptors are blocked by naloxone, bre...
  • What exactly does naloxone injection do in an overdose?
  • Call 911 immediately — that's not optional. Naloxone wears off faster than most opioids, so even if the person wakes up and seems okay, they can slip back into overdose once the na...
  • What do I do after I give someone a dose of naloxone injection?
📖 Read our full Naloxone Injection guide →

🕸️ Concept Web — How Buprenorphine 11.4 MG / naloxone 2.9 MG Sublingu... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Buprenorphine 11.4 MG / naloxone 2.9 MG Sublingual Tablet [Zubsolv] RxCUI 1597570

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Buprenorphine 1819
    • Naloxone 7242
    • Buprenorphine / naloxone 352364
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Zubsolv 1431077
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Buprenorphine / naloxone Sublingual Tablet 378762
    • Buprenorphine / naloxone Oral Product 1151359
    • Buprenorphine / naloxone Pill 1151360
    • Buprenorphine / naloxone Sublingual Product 1294831
    • Buprenorphine / naloxone Sublingual Tablet [Zubsolv] 1431079
    • Zubsolv Oral Product 1431080
    • Zubsolv Pill 1431081
    • Zubsolv Sublingual Product 1431082
    • +4 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Buprenorphine 11.4 MG / naloxone 2.9 MG Sublingual Tablet SCD · 1597568
  • Buprenorphine 11.4 MG SCDC · 1597566
  • Naloxone 2.9 MG SCDC · 1597567
  • Buprenorphine / naloxone Sublingual Tablet SCDF · 378762
  • Buprenorphine / naloxone Oral Product SCDG · 1151359
  • Buprenorphine / naloxone Pill SCDG · 1151360
  • Buprenorphine / naloxone Sublingual Product SCDG · 1294831

Brand-Name Concepts

  • Buprenorphine 11.4 MG / naloxone 2.9 MG [Zubsolv] SBDC · 1597569
  • Buprenorphine / naloxone Sublingual Tablet [Zubsolv] SBDF · 1431079
  • Zubsolv Oral Product SBDG · 1431080
  • Zubsolv Pill SBDG · 1431081
  • Zubsolv Sublingual Product SBDG · 1431082
  • Zubsolv BN · 1431077

📦 FDA Products & Package NDCs

12 products · 12 package NDCs
12 package NDCs map to RxCUI 1597570 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
54123-0114-30 3 BLISTER PACK in 1 CARTON (54123-114-30) / 10 TABLET, ORAL... Zubsolv Orexo US, Inc. 2014-12-11
54123-0907-30 3 BLISTER PACK in 1 CARTON (54123-907-30) / 10 TABLET, ORAL... Zubsolv Orexo US, Inc. 2013-07-04
54123-0914-30 3 BLISTER PACK in 1 CARTON (54123-914-30) / 10 TABLET, ORAL... Zubsolv Orexo US, Inc. 2013-07-04
54123-0929-30 3 BLISTER PACK in 1 CARTON (54123-929-30) / 10 TABLET, ORAL... Zubsolv Orexo US, Inc. 2013-07-04
54123-0957-30 3 BLISTER PACK in 1 CARTON (54123-957-30) / 10 TABLET, ORAL... Zubsolv Orexo US, Inc. 2013-07-04
54123-0986-30 3 BLISTER PACK in 1 CARTON (54123-986-30) / 10 TABLET, ORAL... Zubsolv Orexo US, Inc. 2014-12-11
82111-0201-30 3 BLISTER PACK in 1 CARTON (82111-201-30) / 10 TABLET, ORAL... Zubsolv Edenbridge Pharmaceuticals LLC. 2026-06-12
82111-0202-30 3 BLISTER PACK in 1 CARTON (82111-202-30) / 10 TABLET, ORAL... Zubsolv Edenbridge Pharmaceuticals LLC. 2026-06-12
82111-0203-30 3 BLISTER PACK in 1 CARTON (82111-203-30) / 10 TABLET, ORAL... Zubsolv Edenbridge Pharmaceuticals LLC. 2026-06-12
82111-0204-30 3 BLISTER PACK in 1 CARTON (82111-204-30) / 10 TABLET, ORAL... Zubsolv Edenbridge Pharmaceuticals LLC. 2026-06-12
82111-0205-30 3 BLISTER PACK in 1 CARTON (82111-205-30) / 10 TABLET, ORAL... Zubsolv Edenbridge Pharmaceuticals LLC. 2026-06-12
82111-0206-30 3 BLISTER PACK in 1 CARTON (82111-206-30) / 10 TABLET, ORAL... Zubsolv Edenbridge Pharmaceuticals LLC. 2026-06-12
Observed labelers: Edenbridge Pharmaceuticals LLC. (6) · Orexo US, Inc. (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.